Top Banner
Pharmaceutical Companies and Social Media: Developing New Strategies Jena Cutie [email protected] Karthika Karindalam [email protected]
26

II-SDV 2013 Pharmaceutical Companies and Social Media: Developing New Strategies

Nov 30, 2014

Download

Internet

 
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: II-SDV 2013 Pharmaceutical Companies and Social Media: Developing New Strategies

Pharmaceutical Companies and

Social Media: Developing New

Strategies

Jena Cutie

[email protected]

Karthika Karindalam

[email protected]

Page 2: II-SDV 2013 Pharmaceutical Companies and Social Media: Developing New Strategies

1

2

3

2

Executive Summary

Best Practices and Strategies

Pharma Industry Trends

Page 3: II-SDV 2013 Pharmaceutical Companies and Social Media: Developing New Strategies

Executive Summary

How do we

benchmark social

achievements?

Best Practices and Strategies

Where on social

media should

pharma engage?

Pharma‘s audience is

larger on Facebook

but Twitter yields

higher ROI

What drives

consumers to be

social about health?

Pharmaceutical Industry Trends

Sanofi, AstraZeneca,

Pfizer, Roche, and

J&J dominate

pharma‘s social

media landscape

Where are pharma‘s

social media

success stories?

Consumers are drawn

to official healthcare

providers on social

media because they

crave more care

Benchmarking social

media ROI shows

achievement builds up

in phases

3

Page 4: II-SDV 2013 Pharmaceutical Companies and Social Media: Developing New Strategies

Pharma online marketing reached $1 Billion in 2010

Marketing is turning social—even in the pharma industry

4

Page 5: II-SDV 2013 Pharmaceutical Companies and Social Media: Developing New Strategies

Best Practices and Strategies

Benchmarking social

media ROI shows

achievement builds up

in phases

5

How do we

benchmark social

achievements?

Part I — What is social ROI?

Definitions:

• Social feedback

• Engagement and trust

• Proxy ROI model for Twitter

Conclusion:

Sanofi and AstraZeneca

attain highest levels of

engagement and trust

Page 6: II-SDV 2013 Pharmaceutical Companies and Social Media: Developing New Strategies

more content

content

comments

pharma

pharma

consumer

Consumers

engage

content

Pharma can review

comments, fine tune

messages, and release

more content

Social investment generates its own feedback

6

Page 7: II-SDV 2013 Pharmaceutical Companies and Social Media: Developing New Strategies

―Engagement‖ and ―trust‖ are proxies for return on investment

Trust

Likes on

messages on

Facebook

Followers

on Twitter

sentimentEngagement

User vs.

company

messages

User vs.

company

tweets

activity

Following

on Twitter

Likes on

Facebook

pages

Positive vs.

negative

posts

Retweeted

on Twitter

Retweets

on Twitter

7

Page 8: II-SDV 2013 Pharmaceutical Companies and Social Media: Developing New Strategies

Pharma Benchmarks

very high

high

low

Q20Pharma engagement levels develop in phases

Peak Engagement ROI Score

very low

90percentile

(retweets/tweets)

T8

0.8

0.8

1

1

1

1

1

1

1.8

2

4.8

9

0 1 2 3 4 5 6 7 8 9 10

Astellas

Eli Lilly

Bayer

Boehringer-Ingelheim

Johnson & Johnson

Novo Nordisk

Pfizer

Roche

Merck

Glaxo-Smith Kline

Sanofi

AstraZeneca

All Twitter pages over 24 months(Jan 2011- Dec 2012)

Page 9: II-SDV 2013 Pharmaceutical Companies and Social Media: Developing New Strategies

Pharma Benchmarks

very high

high

medium

low

very low

Q20Sanofi & AstraZeneca‘s trust level is superior

Peak Trust ROI Score90percentile

(retweeted/tweets)

T9

1.8

2

2

2

5.8

6

6.8

9

11.6

11.6

22.4

24.2

25.4

25.8

30.6

34

37.6

45.8

48.8

64.6

65.6

0 10 20 30 40 50 60 70

Merck KGAA

Baxter

Gilead

Hospira

Abbott

Amgen

Bausch + Lomb

Eli Lilly

Astellas

Bayer

Takeda

Boehringer-Ingelheim

Novo Nordisk

Roche

Johnson & Johnson

Pfizer

Merck

Glaxo-Smith Kline

Novartis

AstraZeneca

Sanofi

All Twitter pages over 24 months(Jan 2011- Dec 2012)

Page 10: II-SDV 2013 Pharmaceutical Companies and Social Media: Developing New Strategies

10

Engagement & trust depend on content over volume

T10

Astrazeneca

Sanofi

GSKMerck

NovartisMerck KgAA

PfizerJ&J

Roche

Boehringer

Low Engagement

Size by Average Activity over 24 months

All Twitter pages over 24 months(Jan 2011- Dec 2012)

High Engagement

Low Trust

Low Trust

High Engagement

High Trust

Low Engagement

High Trust

Page 11: II-SDV 2013 Pharmaceutical Companies and Social Media: Developing New Strategies

Best Practices and Strategies

Sanofi, AstraZeneca

Pfizer, Roche, and

J&J dominate

pharma‘s social

media landscape

Where are pharma‘s

social media

success stories?

11

Part II —Where does pharma have social success?

Early adoption is key

strategy to attain high

fidelity presence

Definitions:

•social feedback loop

• engagement and

trust

• proxy ROI model for

Twitter

Twitter findings:

Sanofi and Roche

attain high levels of

engagement, highest

level of trust

Page 12: II-SDV 2013 Pharmaceutical Companies and Social Media: Developing New Strategies

2005 2006 2007 2008 2009 2011 2012

First pharmaceutical corporate

and product blogPharmaceuticalas start blogging

Johnson & Johnson‘s JNJBTW

Pfizer‘s THINK SCIENCE NOW

Glaxo‘s QUESTION EVERYTHING

First pharma Rx

branded Youtube

channelPharma‘s first social game

Boehringer‘s SYRUM

GAMEFirst pharma-sponsored

Youtube video

First pharma youtube

channel & facebook

page

Novo Nordisk and Bayer first to join Pinterest

http://www.news.pharma-mkting.com/pmn1010-article01.pdf

Early adoption is a key indicator of dominance on social media

Roche and Pfizer are first to launch Google+ pages

5.9

4

3.9

9

0.9

4

0.6

2

0.5

1

0.4

8

0.4

2

0.3

6

0.3

0

0.1

9

0.1

4

0.0

9

0.0

7

0.0

6

0.0

4

0.0

3

0.0

3

0.0

1

0.0

1

0.0

0

0.0

0

0.0

0

0

1

2

3

4

5

6

Mil

lio

ns

Early adopters rewarded with high fidelity presence

Supporters of Pharma on Social MediaCalculated monthly using ―Likes this page‖ on Facebook and ―Followers‖ on Twitter

TF12

Page 13: II-SDV 2013 Pharmaceutical Companies and Social Media: Developing New Strategies

0

5,000

10,000

15,000

20,000

25,000Audience Growth on Facebook

Roche Boehringer Sanofi

Boehringer enjoys benefits of early

social media initiation on its

main corporate page

Boehringer

Roche

Sanofi

Lik

es

this

pa

ge

Data from main corporate Facebook page for three companies

Success is influenced by early social media initiation

Boehringer‘s social presence

drives more fans to Facebook over

Sanofi, a competitor and a

relatively late social media entrant

F13

Page 14: II-SDV 2013 Pharmaceutical Companies and Social Media: Developing New Strategies

Where on social

media should

pharma engage?

Pharma‘s audience is

larger on Facebook

but Twitter yields

higher ROI

Pharmaceutical Industry Trends

14

Part III — Where and how can pharma engage?

Influence is better

than audience:

• Facebook has biggest audience

• Twitter has biggest influence

Smart behavior:

• Ask questions

• Be personal

•Calls to action

Definitions:

•social feedback loop

• engagement and

trust

• proxy ROI model for

Twitter

Twitter findings:

Sanofi and

AstraZeneca attain

high levels of

engagement, highest

level of trust

How to win:

Early adoption is key

strategy to attain high

fidelity presence

Best Practices and

Strategies

Page 15: II-SDV 2013 Pharmaceutical Companies and Social Media: Developing New Strategies

Pharma‘s popularity is larger on Facebook

3.0 3.1 3.1

57.562.0 64.0

0

20

40

60

80

Nov-12 Dec-12 Jan-13

Au

die

nce

(Th

ou

san

ds)

―Audience‖ on Facebook and Twitter

Twitter Facebook

Average audience per page over all pages from Nov 2012 – Jan 2013 TF15

Facebook

audience ≈

‗Likes this

page‘

Twitter

audience ≈

‗Followers‘ J&J (27%)GSK (14%)Pfizer (9%)

J&J (27%)GSK (14%)Pfizer (8%)

J&J (27%)GSK (13%)Roche (10%)

J&J (38%)Pfizer (33%)

J&J (34%)Pfizer (28%)GSK (14%)

J&J (33%)Pfizer (28%)GSK (14%)

Page 16: II-SDV 2013 Pharmaceutical Companies and Social Media: Developing New Strategies

Pharma‘s influence is superior on Twitter

34.9

76.0

47.1

34.7 34.2 32.3

0

10

20

30

40

50

60

70

80

Nov-12 Dec-12 Jan-13

Infl

ue

nce

(p

er

Tho

usa

nd

)

―Influence‖ on Twitter and Facebook

Twitter Facebook

Average influence per page over all pages from Nov 2012 – Jan 2013 TF16

Facebook

influence ≈

‗Talking about

this‘ per 1K

audience

Twitter has power to influence its

audience beyond Facebook

Twitter

influence ≈

Retweeted per

1K audience

members

Page 17: II-SDV 2013 Pharmaceutical Companies and Social Media: Developing New Strategies

On Twitter, asking questions generates more feedback

0

10

20

30

40

50

60

0 50 100 150 200 250

Use

r Tw

ee

ts

Company Tweets with Questions

Impact of Interactivity on

Volume of Feedback

Only about 13% of pharma tweets only

contain questions

Boiling down industry

data yields positive

correlation between

interactivity and user

engagement

Interactivity

calculated from

tweets with

questions

Data trend from all pages Nov 2012 – Jan 2013

Good news: responses

are not typically

inquiries requiring

company action

10%

90%

Responses

Questions

Non-

Questions

For example @Diabetes_Sanofi asks questions in

22% of tweets but questions are less than 1% of

user tweets

Interactivity encourages feedback

T17

Page 18: II-SDV 2013 Pharmaceutical Companies and Social Media: Developing New Strategies

On Twitter, personalization and calls to action have an impact

Pharma can improve user

engagement on Twitter with

interpersonal content and

calls to action

5.63%

1.90%

6.42%

1.98%

0%

1%

2%

3%

4%

5%

6%

7%

with personal words without personal words with call to action without call to action

User Engagement as Percent of Total Tweets

Personal content includes

words like ‗you‘

Calls to action include

words like ‗do‘ or ‗go‘ or

‗watch‘ or ‗see‘ or ‗visit‘

@MyAlli weight loss has higher number personal words @Excedrin has more calls to action than other feeds T18

Page 19: II-SDV 2013 Pharmaceutical Companies and Social Media: Developing New Strategies

What drives

consumers to be

social about health?

Pharmaceutical Industry Trends

Consumers are drawn

to official healthcare

providers on social

media because they

crave more care

19

Part IV — What drives consumers to pharma?

Influence is better

than audience:

• Facebook has

biggest audience

• Twitter has

biggest influence

How to win smart :

• Be personal

• Ask questions

•Use calls to action

• Therapies

triumph over

brands

• Diabetes and

cardiovascular lead

the pack

• Targeting geo-

segments pays off

• Customer-

oriented activities

create interest

Definitions:

•social feedback loop

• engagement and

trust

• proxy ROI model for

Twitter

Twitter findings:

Sanofi and

AstraZeneca attain

high levels of

engagement, highest

level of trust

How to win:

Early adoption is key

strategy to attain high

fidelity presence

Best Practices and

Strategies

Page 20: II-SDV 2013 Pharmaceutical Companies and Social Media: Developing New Strategies

Consumer engagement peaks at higher level when content addresses specific therapy focus

Facebook data 2010-Jan 2013

ROI for therapy pages 10 times more than corporate pages

F20

General pages = Corporate Brand Pages

Therapies = Campaign, Biotech, Therapy,

Prescription, Diagnostics, Devices, etc.

Roche has no general pages so all pages

reflect elevated consumer interest

Page 21: II-SDV 2013 Pharmaceutical Companies and Social Media: Developing New Strategies

Social Media data from Oct 2011- Jan 2013

Diabetes and cardiovascular are top therapies on social media

F21

In addition to official corporate pages, many companies

maintain dedicated pages promoting certain therapies

Page 22: II-SDV 2013 Pharmaceutical Companies and Social Media: Developing New Strategies

Roche target audience across different geographies through dedicated

pages to promote awareness, diagnosis and Accu-Check management

Roche‘s diabetes content is very geo-specific

22

Page 23: II-SDV 2013 Pharmaceutical Companies and Social Media: Developing New Strategies

@Power2EndStroke on Twitter is

intended for US fans to share info

Sanofi‘s Power2EndStroke cardiovascular page attracts

consumers from many countries globally

T23

Sanofi maintains content for stroke and Atrial

Fibrillation awareness and education on

@Power2EndStroke

Page 24: II-SDV 2013 Pharmaceutical Companies and Social Media: Developing New Strategies

AstraZeneca engage audience with

customer oriented activities like Live Twitter chats

T24

AstraZeneca wins Healthcare

Engagement Strategy 2012‘s Open

Dialogue Award for its experiment

in Live Twitter chats

AstraZeneca hosts 1-hour live

Twitter chat promoting prescription

savings program ‗AZ& me‘

Live interaction with the company

generated a positive feel and

potential opportunity to expand

customer base

Page 25: II-SDV 2013 Pharmaceutical Companies and Social Media: Developing New Strategies

How to win first:

Early adoption is key

strategy to attain high

fidelity presence

Definitions:

•social feedback loop

• engagement + trust

• proxy ROI model for

Twitter

Twitter findings:

Sanofi and

AstraZeneca attain

high levels of

engagement, highest

level of trust

Pharmaceutical

Industry Trends

25

Pharma Benefits from Social Media

Influence is better

than audience:

• Facebook has

biggest audience

• Twitter has

biggest influence

How to win smart :

• Be personal

• Ask questions

•Use calls to action

Consumers prefer:

• Therapies over

brands

• Diabetes and

cardiovascular

• Geo-specificity

• Consumer focus

Best Practices and

Strategies

Step 1: Start Early

Being first in market gives pharma

companies an advantage

Step 2: Start Smart

Even a company not starting early

can join the race and win by being

smarter

Step 3: Don‘t Stop

ROI advances as consumers

become more and more keen to

connect with the source of their

healthcare via social media

Page 26: II-SDV 2013 Pharmaceutical Companies and Social Media: Developing New Strategies

Our social media data, analytics, and trends

for all major pharmaceutical companies is comprehensive

26